AvengeBio Funding: $45M Raised, Series A (2022)

AvengeBio funding overview

AvengeBio is based in Natick, Massachusetts. AvengeBio has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for AvengeBio runs through 2022; nothing later has been disclosed. Investors on record include Perceptive Xontogeny Venture Fund, CAM Capital, Longitude Capital, Rock Springs Capital, Pappas Capital. 5 distinct backers are named across the disclosed rounds.

AvengeBio at a glance

Total raised: $45M
Latest round: Series A
Latest round date: January 2022
Headquarters: Natick, Massachusetts
Notable investors: Perceptive Xontogeny Venture Fund, CAM Capital, Longitude Capital, Rock Springs Capital, Pappas Capital

Frequently asked about AvengeBio funding

How much has AvengeBio raised?: AvengeBio has raised $45M in total disclosed funding across the rounds on record.
Who has invested in AvengeBio?: Perceptive Xontogeny Venture Fund, CAM Capital, Longitude Capital, Rock Springs Capital, Pappas Capital are named among the investors backing AvengeBio.
What was the latest AvengeBio funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is AvengeBio based?: AvengeBio is based in Natick, Massachusetts.
When did AvengeBio last raise?: The last disclosed AvengeBio round closed in January 2022 at Series A.

Every AvengeBio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Natick at a similar stage.

AvengeBio Funding: $45M Raised, Series A (2022)

AvengeBio funding overview

AvengeBio at a glance

Frequently asked about AvengeBio funding

Companies related to AvengeBio (14)

Browse related funding lists (5)